BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7005428)

  • 1. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ; Hintze TH; Kaley G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
    Schwertschlag U; Stahl T; Hackenthal E
    Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal artery constriction increases renal prostaglandin I2 biosynthesis and renin release in the conscious dog.
    Jackson EK; Gerkens JF; Brash AR; Branch RA
    J Pharmacol Exp Ther; 1982 Aug; 222(2):410-3. PubMed ID: 7047717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK; Goodman RP; Fitzgerald GA; Oates JA; Branch RA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):183-7. PubMed ID: 7038095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intravitreal and topical prostaglandins on intraocular inflammation.
    Kulkarni PS; Srinivasan BD
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of PGE2, 6-keto PGF1 alpha and renin release from dog kidneys.
    Bugge JF; Vikse A; Dahl E; Slørdahl SH; Kiil F
    Acta Physiol Scand; 1986 Jun; 127(2):197-205. PubMed ID: 3088915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed.
    Feigen LP; Chapnick BM; Hyman AL; King L; Marascalco B; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):528-34. PubMed ID: 6995573
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal prostaglandins E2 and I2. Aspects of metabolism, and relationship to renal hemodynamics and renin release mechanisms.
    Bugge JF
    J Oslo City Hosp; 1989; 39(11-12):123-36. PubMed ID: 2693665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin-related renin release from rabbit renal cortical slices.
    Spokas EG; Wong PY; McGiff JC
    Hypertension; 1982; 4(3 Pt 2):96-100. PubMed ID: 7040243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV; Aiken JW; Shebuski RJ; Gorman RR
    Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandin I2 and E2 on renal hemodynamics and function and renin release.
    Imanishi M; Abe Y; Okahara T; Yukimura T; Yamamoto K
    Jpn Circ J; 1980 Nov; 44(11):875-82. PubMed ID: 7001085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.
    Jackson EK; Heidemann HT; Branch RA; Gerkens JF
    Circ Res; 1982 Jul; 51(1):67-72. PubMed ID: 7044603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-keto-PGE1 exhibits more potent bronchodilatory activity in the cat than its precursor, PGI2.
    Spannhake EW; Levin JL; Hyman AL; Kadowitz PJ
    Prostaglandins; 1981 Feb; 21(2):267-75. PubMed ID: 7012934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pulmonary, hepatic and renal extraction of PGI2 and 6-keto-PGE1.
    Tsunoda S; Jackson EK; Branch RA; Gerkens JF
    Eur J Pharmacol; 1982 Jan; 77(2-3):147-51. PubMed ID: 7037431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
    McGiff JC; Spokas EG; Wong PY
    Br J Pharmacol; 1982 Jan; 75(1):137-44. PubMed ID: 7042021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of renin release by PGE2 and PGI2 infusion in the dog: enhancing effect of ureteral occlusion or administration of ethacrynic acid.
    Bugge JF; Stokke ES; Vikse A; Kiil F
    Acta Physiol Scand; 1990 Feb; 138(2):193-201. PubMed ID: 2107658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental vascular responses to 6-keto-prostaglandin E1 in the near-term sheep.
    Schwartz DB; Phernetton TM; Stock MK; Rankin JH
    Am J Obstet Gynecol; 1983 Feb; 145(4):406-10. PubMed ID: 6337494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal vasodilation with ureteral occlusion and prostaglandins: attenuation by histamine H1 antagonists.
    Banks RO; Jacobson ED
    Am J Physiol; 1985 Dec; 249(6 Pt 2):F851-7. PubMed ID: 2866716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.